Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Benign Essential Blepharospasm: later-stage trial registry

1 of 2 indexed Benign Essential Blepharospasm trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Benign Essential Blepharospasm: 2 US clinical trials tracked, 1 recruiting.

Benign Essential Blepharospasm is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Montefiore Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition benign-essential-blepharospasm

OPEN 1 | RECR 50% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Benign Essential Blephar (th…50%
Open-enrollment share among volume-matched conditions near Benign Essential Blepharospasm

Benign Essential Blepharospasm lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Benign Essential Blepharospasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Benign Essential Blepharospasm is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Benign Essential Blepharospasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham Magstim RapidStim2 Device
1 trials
Magstim RapidStim2 Device
1 trials
DaxibotulinumtoxinA Drug
1 trials

US sites by state

Facility locations filed on Benign Essential Blepharospasm trials. A trial with sites in several states counts in each.

New York 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Benign Essential Blepharospasm page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Benign Essential Blepharospasm trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Montefiore Medical Center sponsors the most Benign Essential Blepharospasm trials on record, review their full trial history before evaluating a specific study. See Montefiore Medical Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Benign Essential Blepharospasm condition card totals 2 registered trials; most-linked intervention Sham Magstim RapidStim2; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.